ID
23887
Description
Study part: General Medical History/ Physical Examination Visit 1. A phase 2 study to assess safety, reactogenicity and immunogenicity of a booster dose of an investigational vaccination regimen and GSK Biologicals Hib-MenC vaccine (co-administered with Infanrix penta) compared to a booster dose of Menjugate (co-administered with Infanrix hexa).Patient Level Data: Study Listed on ClinicalStudyDataRequest.com. Study ID: 100381, Clinical Study ID: 100381
Mots-clés
Versions (1)
- 16/07/2017 16/07/2017 -
Détendeur de droits
GlaxoSmithKline
Téléchargé le
16 juillet 2017
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY-NC 3.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
General Medical History/ Physical Examination Visit 1 Hib-MenCY-TT-004 BST 003 Neisseria Meningitidis-Haemophilus influenzae type b Vaccine 100381
General Medical History/ Physical Examination Visit 1
- StudyEvent: ODM
Similar models
General Medical History/ Physical Examination Visit 1
- StudyEvent: ODM
C0221912 (UMLS CUI [1,2])
C0221912 (UMLS CUI [1,2])
C0015392 (UMLS CUI [1,2])
C0015392 (UMLS CUI [1,2])
C0011900 (UMLS CUI [1,2])
C0011900 (UMLS CUI [1,2])
C3887460 (UMLS CUI [1,2])
C3887460 (UMLS CUI [1,2])
C0035237 (UMLS CUI [1,2])
C0035237 (UMLS CUI [1,2])
C0521362 (UMLS CUI [1,2])
C0521362 (UMLS CUI [1,2])
C0026860 (UMLS CUI [1,2])
C0026860 (UMLS CUI [1,2])
C0027765 (UMLS CUI [1,2])
C0027765 (UMLS CUI [1,2])
C0042066 (UMLS CUI [1,2])
C0042066 (UMLS CUI [1,2])
C0474523 (UMLS CUI [1,2])
C0474523 (UMLS CUI [1,2])
C0020517 (UMLS CUI [1,2])
C0020517 (UMLS CUI [1,2])
C0011900 (UMLS CUI [1,2])
C0011900 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,2])